Skip to main content

Table 3 Onset of neurological manifestations stratified by timing of treatment initiation

From: Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reports

Group

Median age at first neurological manifestations (years)

SE

95% CI

p

Symptomatic at start treatment

51

0.6

49.8–52.2

0.001

Asymptomatic at start treatment

61

5.0

51.2–70.8

 
Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172